Definitive Contract 75F40120C00152

Award Date 9/14/20
Potential Completion Date 9/27/21
Potential Value $249K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hartford, CT 06102, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Hartford Hospital, a non-profit hospital in Hartford, Connecticut, with a potential value of $249,794.00. The contract is for research related to "Metallo-B-Lactamase Resistance in Enterobacterales: Is It Time to Rethink Our In Vitro Assessment Tools?". This contract was issued under a Broad Agency Announcement (BAA) that solicits advanced research and...
The Department of Health and Human Services Food and Drug Administration awarded a $249,999.00 definitive contract to Hartford Hospital, a non-profit hospital organization, to conduct research and development in support of regulatory science and innovation. This contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021, which solicits proposals across eight areas of regulatory science to modernize FDA functions. The contract does not have...
The Department of Health and Human Services Food and Drug Administration awarded a $407,720 definitive contract to Hartford Hospital. The contract is for ex vivo modeling, simulation, and in vivo pharmacokinetic validation to guide antimicrobial dosing recommendations for patients on continuous renal replacement therapy. The contract has a start date of September 9, 2022 and end date of September 29, 2024, and utilizes a firm fixed price pricing structure. The place of performance is Hartford,...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Hartford Hospital, a non-profit hospital located in Hartford, Connecticut. The contract, with a potential value of $249,991.00, is for research on the pharmacodynamics of three antibiotics - minocycline, levofloxacin, and trimethoprim/sulfamethoxazole - against the bacterium Stenotrophomonas maltophilia. The goal of the research is to provide data to support potential...
This is a $539,764.16 firm fixed price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract is for emergency medical simulation training services, with a performance period through May 14, 2023. Hartford Hospital has previously conducted research for the Food and Drug Administration and provided clinical services in support of multi-site studies funded by the National...
This is a Firm Fixed Price definitive contract awarded by the Naval Supply Systems Command (NAVSUP) to Hartford Hospital, a non-profit healthcare institution in Hartford, Connecticut. The contract is for $3,900.00 and provides emergency medical training classes. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 30, 2025. There is no set-aside designation indicated for this contract. Hartford Hospital has previously received federal grant awards, primarily...
This federal contract award, valued at $450,714.35, was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Hartford Hospital, a non-profit healthcare institution and subsidiary of Hartford Healthcare Corporation. The contract is for emergency medical simulation training services and does not have a set-aside designation. This award demonstrates Hartford Hospital's expertise in providing advanced medical research and simulation services to federal...
Yale University was awarded a definitive cost-no-fee contract valued at $3.3 million by the Department of Health and Human Services Food and Drug Administration to support the agency's Broad Agency Announcement for Advanced Research and Development of Regulatory Science. The prime contractor will leverage community engagement and electronic health record strategies to promote diverse participation in COVID-19 clinical trials, addressing Research Area 9 under the BAA which seeks proposals to...
The federal contract award is for a definitive contract with the Food and Drug Administration (FDA) for human food inspection services in Hartford, Connecticut. The $372,314.29 firm fixed price contract was awarded on August 29, 2023 to the Connecticut Department of Consumer Protection, a U.S. state government entity, to provide these inspection services from August 2023 through March 2027. This contract was awarded without any set-asides. In addition to the contract award, the Department of...
This is a $1,417,987.00 federal contract awarded by the Food and Drug Administration (FDA) to the University of Connecticut (UConn). The contract is a Definitive Contract without a set-aside designation. The contract involves a comparative trial of different packaging components of an opioid packaging solution to evaluate their impact on opioid safety outcomes. UConn is working with Hartford Hospital and the UConn Health Center as subcontractors on this research project, which aims to identify...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $248,725 Firm Fixed Price contract to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract was awarded under the FDA's Broad Agency Announcement (BAA) seeking advanced research and development proposals to support regulatory science and innovation across multiple areas. Under this contract, Hartford Hospital is conducting comparative efficacy research on antibiotic treatments for infections caused by OXA-48 beta-lactamase-producing Enterobacterales bacteria. The contract has a period of performance ending on September 27, 2021. No set-aside designation is indicated for this award.

Generated 3/22/24, 3:20 PM